ArticleThe journal of allergy and clinical immunology. In practice2022

COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.

Benjamin Ungar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.